Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005423
Filing Date
2025-08-04
Accepted
2025-08-04 18:08:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3226
  Complete submission text file 0001950047-25-005423.txt   4704
Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Lundberg Sven Ante (Reporting) CIK: 0001682126 (see all company filings)

Type: 144

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Subject) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39979 | Film No.: 251181992
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)